 |
|
|
| |
A Clinical Trial Evaluating Low HCV RNA Viremia in Patients Treated with Triple Therapy Including Telaprevir: Implications for Management Using Different Assays in Clinical Practice
|
| |
| |
Reported by Jules Levin
EASL 2013 April 24-28 Amsterdam
Benjamin Maasoumy1, Bryan Cobb2, Birgit Bremer1, Philippe Halfon3,
Kevin Luk2,Shagufta Aslam2, Michael P. Manns1, Markus Cornberg1,
Heiner Wedemeyer1
1Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Hannover, Germany,
2Roche Molecular Systems, Pleasanton, CA, USA,
3Laboratoire ALPHABIO, Hopital Ambroise Pare, Marseille, France
|
| |
|
|
|
|
|
